A study of the physiology of Bacillus anthracis Sterne during manufacture of the UK acellular anthrax vaccine

Journal of Applied Microbiology

Volumn 103, Issue 5, 2007, Pages 1453-1460

  Charlton, S ^a   Herbert, M ^a   McGlashan, J ^a   King, A ^a   Jones, P ^a   West, K ^a   Roberts, A ^a   Silman, N ^a   Marks, T ^a   Hudson, M ^a   Hallis, B ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Anthrax; Lethal factor; Physiology; Protective antigen; Toxin; Vaccine

Indexed keywords

AMINO ACIDS; ANTIGENS; BACTERIOLOGY; DISEASES; ENVIRONMENTAL PROTECTION AGENCY; GLUCOSE; VACCINES;

ANTHRAX; ANTHRAX VACCINES; BACILLUS ANTHRACIS; BACILLUS ANTHRACIS STERNE; LETHAL FACTOR; MANUFACTURING PROCESS; PRODUCTION RUN; PROTECTIVE ANTIGENS; TOXIN; VACCINE PRODUCTION;

PHYSIOLOGY;

ANTHRAX VACCINE; ANTIGEN; CARBON; SERINE;

ANTHRAX; ANTIGEN; BACTERIUM; DRUG DEVELOPMENT; FERMENTATION; GROWTH RATE; MANUFACTURING; PH; PHYSIOLOGY; SPORULATION; TOXIN; VACCINE;

ARTICLE; BACILLUS ANTHRACIS; BACTERIAL STRAIN; BACTERIUM CULTURE; CARBON SOURCE; CELL VIABILITY; DRUG MANUFACTURE; GLUCONEOGENESIS; GLUCOSE INTAKE; GROWTH CURVE; LETHAL GENE; PH; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SIMULATION; SPOROGENESIS; VACCINE PRODUCTION; WESTERN BLOTTING;

BACILLUS ANTHRACIS; BACILLUS ANTHRACIS STR. STERNE;

EID: 35448940554     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2007.03391.x     Document Type: Article

References (20)

1. Belton, F. Strange, R. (1954) Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production. Br J Exp Path 35, 144 152.
2. Deutscher, M.P. Kornberg, A. (1968) Biochemical studies of bacterial sporulation and germination. VIII. Patterns of enzyme development during growth and sporulation of B. subtilis. J Biol Chem 243, 4653 4660.
3. Frachaus, J.W., Ribot, W.J., Jendrek, S. Little, F. (1998) Fermentation, purification, and characterisation of protective antigen from a recombinant, avirulent strain of Bacillus anthracis. Appl Environ Microbiol 64, 982 991.
4. Grossman, A.D. Losick, R. (1988) Extracellular control of spore formation in Bacillus subtilis. Proc Natl Acad Sci USA 85, 4369 4373.
5. Hermanson, G.T. (1996) Bioconjugate Techniques, 1st edn. London : Academic Press Inc.
6. Ivins, B.E., Pitt, M.L.M., Fellows, P.F., Farchaus, J.W., Bener, G.E., Waag, D.M., Little, S.F., Anderson, G.W. Jr., et al. (1998) Comparative efficacy of experimental anthrax vaccine candidates against inhalational anthrax vaccine in rhesus macaques. Vaccine 16, 1141 1148.
7. Joellenbeck, L.M., Zwanziger, L.L., Durch, J.S. Strom, B.L. (Eds) (2002) The Anthrax Vaccine: Is It Safe? Does It Works? Washington, DC : Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Medical Follow-Up Agency, National Academy Press (http://www.nap.edu/catalog/10310.html).
8. Jones, M.B. Blaser, M.J. (2003) Detection of a luxS-signaling molecule in Bacillus anthracis. Infect Immun 71, 3914 3919.
9. Jones, M.B., Jani, R., Ren, D., Wood, T.K. Blaser, M.J. (2005) Inhibition of Bacillus anthracis growth and virulence-gene expression by inhibitors of quorum-sensing. J Infect Dis 191, 1881 1888.
10. King, A., Herbert, M., Charlton, S., Anlezark, G., Marks, T. Hallis, B. (2006) Development and qualification of immunological and functional assasys to quantify anthrax lethal toxin, its components and immune response. In ASM Biodefence Research Meeting, Program and Abstracts Book. American Society for Microbiology, p. 67.
11. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55 63.
12. Pezard, C., Weber, M., Sirard, J.-C., Berche, P. Mock, M. (1995) Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect Immun 63, 1369 1372.
13. Price, B.M., Liner, A.L., Park, S., Leppla, S.H., Mateczun, A. Galloway, D.R. (2001) Protection against anthrax lethal toxin challenge by genetic immunisation with a plasmid encoding the lethal factor protein. Infect Immun 69, 4509 4515.
14. Puziss, M. Wright, G.G. (1959) Studies on immunity in anthrax VII. Carbohydrate metabolism of Bacillus anthracis in relation to elaboration of protective antigen. J Bacteriol 78, 137 145.
15. Puziss, M., Manning, L.C., Lynch, J.W., Barclay, E., Abelow, I. Wright, G.G. (1963) Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures. Appl Microbiol 11, 330 334.
16. Quinn, C.P., Singh, Y., Klimpel, K.R. Leppla, S.H. (1991) Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis. J Biol Chem 266, 20124 20130.
17. Singh, A., Singh, S., Waheed, S.M., Khandelwal, P. Bhatnagar, R. (2002) Expression of anthrax lethal factor by osmolyte induction. FEMS Microbiol Lett 209, 301 305.
18. Stephens, C. (1998) Bacterial sporulation: a question of commitment? Curr Biol 8, R45 R48.
19. Sterne, M. (1939) The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis. Onderstepoort J Vet Sci Anim Ind 13, 307 312.
20. Wright, G.G., Hedberg, M.A. Slein, J.B. (1954) Studies on immunity in anthrax III: elaboration of Protective Antigen in a chemically-defined nonprotein medium. J Immunol 72, 263 269.